Latest On Sage Therapeutics, Inc (SAGE):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 17:58 EST | News | Sage Therapeutics: Mid-2023 Data Readout And Possible FDA Approval Make This A Must Watch | N/A |  |
| 2023-05-03 02:24 EST | News | Sage Therapeutics, Inc. (SAGE) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 14:08 EST | News | Sage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02M | N/A | |
| 2023-05-01 13:35 EST | News | Sage Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-03-13 18:37 EST | News | Sage upgraded to outperform at RBC on greater confidence in zuranolone approval | N/A | |
| 2023-03-08 15:36 EST | News | FDA to not hold panel meeting for Biogen, Sage's depression therapy zuranolone | N/A | |
| 2023-02-22 17:22 EST | News | Sage's therapy for Huntington's disease gets orphan drug status in EU | N/A | |
| 2023-02-21 15:46 EST | News | Sage Therapeutics Looking To FDA Approval Of Zuranolone | N/A | |
| 2023-02-16 18:12 EST | News | Sage Therapeutics mixed Q4 earnings; initiates FY23 outlook | N/A | |
| 2023-02-16 18:12 EST | News | Sage Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-16 18:12 EST | News | Sage Therapeutics, Inc. (SAGE) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-06 08:46 EST | News | Biogen, Sage win FDA priority review for depression therapy | N/A | |
| 2023-01-10 13:49 EST | News | Sage Therapeutics sees depression treatment zuranolone hitting the market as early as Q3 | N/A | |
| 2022-12-13 11:39 EST | News | Sage Therapeutics Could Be In For A Depressing FDA Review | N/A | |
| 2022-12-10 15:56 EST | News | Sage Therapeutics: Zuranolone NDA Near-Term Tailwind | N/A | |
| 2022-12-07 00:56 EST | News | Sage, Biogen complete rolling filing with FDA for depression therapy zuranolone | N/A | |
| 2022-11-08 18:43 EST | News | Sage Therapeutics GAAP EPS of -$2.31 misses by $0.11, revenue of $1.74M beats by $0.08M | N/A | |
| 2022-11-08 18:42 EST | News | Sage Therapeutics, Inc. (SAGE) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 15:03 EST | News | Sage Therapeutics appoints Laura Gault as Chief Medical Officer | N/A | |
| 2022-08-02 20:37 EST | News | Sage Therapeutics GAAP EPS of -$2.13 beats by $0.02, revenue of $1.5M misses by $0.27M | N/A | |
| 2022-08-02 20:37 EST | News | Sage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-01 15:32 EST | News | Sage Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-06-13 12:22 EST | News | Biogen, Sage to submit a single marketing application for depression candidate | N/A | |
| 2022-06-01 20:21 EST | News | Biogen/Sage's zuranolone helps reduce postpartum depression symptoms, meets main goal of trial | N/A | |
| 2022-05-03 20:09 EST | News | Sage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65M | N/A | |
| 2022-05-03 20:09 EST | News | Sage Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-03 20:09 EST | News | Sage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 01:57 EST | News | Sage Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-05-02 08:38 EST | News | Sage, Biogen begin rolling submission with FDA for zuranolone to treat depression | N/A | |
| 2022-04-01 11:49 EST | News | Sage stock rises 15% as drug shows function/learning benefit in Alzheimer’s patients with dementia | N/A | |
| 2022-03-30 23:35 EST | News | Sage Therapeutics (SAGE) presents at 2022 Stifel CNS Days - Slideshow | N/A | |
| 2022-03-24 23:14 EST | News | Sage Therapeutics: Well-Funded But Uninspiring Data | N/A | |
| 2022-03-15 09:02 EST | News | Sage Therapeutics drug benefits cognitive function in phase 2 trial in Parkinson’s | N/A | |
| 2022-03-01 12:26 EST | News | Sage Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-24 18:37 EST | News | Sage Therapeutics GAAP EPS of -$2.12 beats by $0.05, revenue of $1.6M misses by $0.17M | N/A | |
| 2022-02-24 18:36 EST | News | Sage Therapeutics' (SAGE) CEO Barry Greene on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-24 01:32 EST | News | Sage Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-02-17 03:14 EST | News | Sage, Biogen announce late-stage trial for depression therapy met key goals | N/A | |
| 2022-02-01 14:17 EST | News | New thematic psychedelic ETF hits the market | N/A | |
| 2022-01-13 04:09 EST | News | Sage Therapeutics (SAGE) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2022-01-04 02:08 EST | News | Sage Therapeutics: Biogen's Backing May See It Through | N/A | |
| 2021-12-08 12:43 EST | News | Sage Therapeutics, Biogen reports new analyses from Landscape program of zuranolone in MDD | N/A | |
| 2021-12-01 08:17 EST | News | Sage Therapeutics, Biogen report positive zuranolone data in late-stage depression study | N/A | |
| 2021-11-02 22:49 EST | News | Sage Therapeutics EPS misses by $0.36, misses on revenue | N/A | |
| 2021-11-02 22:49 EST | News | Sage Therapeutics posts Q3 earnings miss, pipeline update | N/A | |
| 2021-11-02 22:48 EST | News | Sage stock hits 52-week low as departure of medical chief follows earnings miss | N/A | |
| 2021-11-02 22:47 EST | News | SAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-02 22:47 EST | News | Sage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-02 03:24 EST | News | Sage Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-10-19 17:36 EST | News | Biogen, Sage expect marketing application for depression therapy in H2 2022 | N/A | |
About Sage Therapeutics, Inc (SAGE):
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, bipolar depression, and generalized anxiety disorders; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
General
- Name Sage Therapeutics, Inc
- Symbol SAGE
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 298
- Fiscal Year EndDecember
- IPO Date2014-07-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.sagerx.com
View More
Valuation
- Trailing PE 6.57
- Price/Sales (Trailing 12 Mt.) 3.76
- Price/Book (Most Recent Quarter) 2.23
- Enterprise Value Revenue 2.28
- Enterprise Value EBITDA 4.05
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$7.73
- Next Year EPS Estimate -$6.01
- Next Quarter EPS Estimate $0.75
- Profit Margin 54%
- Operating Margin 56%
- Return on Assets 24%
- Return on Equity 40%
- Revenue 1.11 billion
- Earnings Per Share $11.43
- Revenue Per Share $21.43
- Gross Profit 820.92 million
- Quarterly Earnings Growth 56491.1%
View More
Highlights
- Market Capitalization 4.38 billion
- EBITDA 626.6 million
- PE Ratio -1.15
- PEG Ratio 0.74
- Analyst Target Price $102.21
- Book Value Per Share $35.54
View More
Share Statistics
- Shares Outstanding 58.38 million
- Shares Float 51.18 million
- % Held by Insiders 161%
- % Held by Institutions 93.8%
- Shares Short 5.2 million
- Shares Short Prior Month 5.1 million
- Short Ratio 10.41
- Short % of Float 12%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 2.05
- 52 Week High $98.39
- 52 Week Low $25.25
- 50 Day Moving Average 80.49
- 200 Day Moving Average 74.68
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Sage Therapeutics, Inc (SAGE) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sage Therapeutics, Inc (SAGE) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $1.11 billion | $18.19 | -$2.12 | 959.26% |
| 2020-09-30 | 2020-11-05 | $1.64 million | -$2.04 | -$2.47 | 17.25% |
| 2020-06-30 | 2020-08-10 | $N/A | -$2.08 | -$2.59 | 19.67% |
| 2020-03-31 | 2020-05-07 | $2.29 million | -$2.44 | -$3.17 | 22.99% |
| 2019-12-31 | 2020-02-27 | $1.96 million | -$3.25 | -$3.63 | 10.53% |
| 2019-09-30 | 2019-11-12 | $3.57 million | -$3.48 | -$3.38 | -3.02% |
| 2019-06-30 | 2019-08-06 | $873000 | -$3.28 | -$3.35 | 2.04% |
| 2019-03-31 | 2019-05-02 | $465000 | -$3.37 | -$3.19 | -5.73% |
| 2018-12-31 | 2019-02-19 | $273000 | -$3.38 | -$2.92 | -15.89% |
| 2018-09-30 | 2018-11-06 | $-90000000 | -$2.63 | -$2.40 | -9.38% |
| 2018-06-30 | 2018-08-07 | $90 million | -$0.36 | -$1.82 | 80.24% |
| 2018-03-31 | 2018-05-03 | $N/A | -$1.68 | -$1.81 | 7.31% |
| 2017-12-31 | 2018-02-22 | $N/A | -$1.75 | -$2.01 | 13.1% |
| 2017-09-30 | 2017-11-02 | $N/A | -$1.97 | -$1.93 | -2.03% |
| 2017-06-30 | 2017-08-03 | $N/A | -$1.88 | -$1.63 | -15.05% |
| 2017-03-31 | 2017-05-09 | $N/A | -$1.52 | -$1.55 | 1.94% |
| 2016-12-31 | 2017-02-23 | $N/A | -$1.50 | -$1.17 | -27.79% |
| 2016-09-30 | 2016-11-03 | $N/A | -$1.15 | -$1.09 | -5.49% |
| 2016-06-30 | 2016-08-09 | $N/A | -$1.08 | -$1.01 | -7.16% |
| 2016-03-31 | 2016-05-05 | $N/A | -$0.97 | -$0.97 | 0% |
| 2015-12-31 | 2016-02-24 | $N/A | -$0.99 | -$0.94 | -5.34% |
| 2015-09-30 | 2015-11-05 | $N/A | -$0.84 | -$0.83 | -1.2% |
| 2015-06-30 | 2015-08-12 | $N/A | -$0.90 | -$0.68 | -32.35% |
| 2015-03-31 | 2015-05-14 | $N/A | -$0.66 | -$0.49 | -34.69% |
| 2014-12-31 | 2015-02-27 | $N/A | -$0.57 | -$0.43 | -32.56% |
| 2014-09-30 | 2014-11-11 | $N/A | -$0.50 | -$0.40 | -25% |
| 2014-06-30 | 2014-08-14 | $N/A | -$4.57 | -$1.23 | -271.54% |
Sage Therapeutics, Inc (SAGE) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Sage Therapeutics, Inc (SAGE) Chart:
Sage Therapeutics, Inc (SAGE) News:
Below you will find a list of latest news for Sage Therapeutics, Inc (SAGE) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sage Therapeutics, Inc (SAGE) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2.5 | 0 | CALL | 0 | 0 | 327.89 | TRUE | 0 | 0 |
| 2025-09-19 | 5 | 0 | CALL | 0 | 0 | 168.59 | TRUE | 0 | 0 |
| 2025-09-19 | 7.5 | 1.38 | CALL | 0 | 190 | 36.73 | TRUE | 0 | 0 |
| 2025-09-19 | 10 | 0 | CALL | 0 | 0 | 24.25 | FALSE | 0 | 0 |
| 2025-09-19 | 12.5 | 0 | CALL | 0 | 0 | 100.47 | FALSE | 0 | 0 |
| 2025-09-19 | 15 | 0 | CALL | 0 | 0 | 154.41 | FALSE | 0 | 0 |
| 2025-09-19 | 17.5 | 0 | CALL | 0 | 0 | 150.39 | FALSE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | PUT | 0 | 0 | 354.98 | FALSE | 0 | 0 |
| 2025-09-19 | 5 | 0 | PUT | 0 | 0 | 181.69 | FALSE | 0 | 0 |
| 2025-09-19 | 7.5 | 0 | PUT | 0 | 0 | 27.36 | FALSE | 0 | 0 |
| 2025-09-19 | 10 | 1.55 | PUT | 0 | 104 | 51.57 | TRUE | 0 | 0 |
| 2025-09-19 | 12.5 | 0 | PUT | 0 | 0 | 63.73 | TRUE | 0 | 0 |
| 2025-09-19 | 15 | 0 | PUT | 0 | 0 | 87.54 | TRUE | 0 | 0 |
| 2025-09-19 | 17.5 | 0 | PUT | 0 | 0 | 106.8 | TRUE | 0 | 0 |
| 2025-11-21 | 2.5 | 0 | CALL | 0 | 0 | 206.64 | TRUE | 0 | 0 |
| 2025-11-21 | 5 | 0 | CALL | 0 | 0 | 101.28 | TRUE | 0 | 0 |
| 2025-11-21 | 7.5 | 1.2 | CALL | 0 | 57 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 10 | 0.05 | CALL | 0 | 2968 | 18.52 | FALSE | 0 | 0 |
| 2025-11-21 | 12.5 | 0 | CALL | 0 | 40 | 34.03 | FALSE | 0 | 0 |
| 2025-11-21 | 15 | 0 | CALL | 0 | 0 | 92.51 | FALSE | 0 | 0 |
| 2025-11-21 | 17.5 | 0 | CALL | 0 | 0 | 99.89 | FALSE | 0 | 0 |
| 2025-11-21 | 2.5 | 0 | PUT | 0 | 0 | 204.2 | FALSE | 0 | 0 |
| 2025-11-21 | 5 | 0.01 | PUT | 0 | 64 | 47.25 | FALSE | 0 | 0 |
| 2025-11-21 | 7.5 | 0.01 | PUT | 0 | 5739 | 15.77 | FALSE | 0 | 0 |
| 2025-11-21 | 10 | 1.55 | PUT | 0 | 801 | 36.96 | TRUE | 0 | 0 |
| 2025-11-21 | 12.5 | 4.3 | PUT | 0 | 1 | 53.63 | TRUE | 0 | 0 |
| 2025-11-21 | 15 | 0 | PUT | 0 | 0 | 64.84 | TRUE | 0 | 0 |
| 2025-11-21 | 17.5 | 0 | PUT | 0 | 0 | 78.94 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 6.2 | CALL | 0 | 4 | 502.44 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 3.7 | CALL | 0 | 479 | 234.79 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 1.1 | CALL | 0 | 82 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 0.03 | CALL | 0 | 2783 | 12.2 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0.05 | CALL | 0 | 458 | 27.44 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0 | CALL | 0 | 68 | 38.54 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 0.25 | CALL | 0 | 90 | 47.39 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 0.05 | CALL | 0 | 133 | 54.76 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | CALL | 0 | 24 | 61.06 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0 | CALL | 0 | 26 | 66.57 | FALSE | 0 | 0 |
| 2026-01-16 | 27.5 | 0 | CALL | 0 | 27 | 71.46 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0.05 | CALL | 0 | 38 | 75.84 | FALSE | 0 | 0 |
| 2026-01-16 | 32.5 | 0 | CALL | 0 | 6 | 226.15 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0 | CALL | 0 | 15 | 231.44 | FALSE | 0 | 0 |
| 2026-01-16 | 37.5 | 0 | CALL | 0 | 0 | 236.26 | FALSE | 0 | 0 |
| 2026-01-16 | 40 | 0.07 | CALL | 0 | 180 | 170.3 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 2 | 93.31 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.02 | PUT | 0 | 850 | 45.18 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0.01 | PUT | 0 | 1433 | 16.01 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 1.55 | PUT | 0 | 1363 | 31.83 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 4.3 | PUT | 0 | 1 | 50.32 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 6.7 | PUT | 0 | 1 | 66.6 | TRUE | 0 | 0 |
| 2026-01-16 | 17.5 | 0 | PUT | 0 | 0 | 68.84 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 0 | PUT | 0 | 0 | 191.95 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | PUT | 0 | 0 | 88.29 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 112.86 | TRUE | 0 | 0 |
| 2026-01-16 | 27.5 | 0 | PUT | 0 | 0 | 103.69 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 110.25 | TRUE | 0 | 0 |
| 2026-01-16 | 32.5 | 0 | PUT | 0 | 0 | 116.27 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 121.85 | TRUE | 0 | 0 |
| 2026-01-16 | 37.5 | 0 | PUT | 0 | 0 | 144.96 | TRUE | 0 | 0 |
| 2026-01-16 | 40 | 0 | PUT | 0 | 0 | 131.94 | TRUE | 0 | 0 |
| 2026-02-20 | 2.5 | 0 | CALL | 0 | 0 | 151.28 | TRUE | 0 | 0 |
| 2026-02-20 | 5 | 0 | CALL | 0 | 0 | 67.03 | TRUE | 0 | 0 |
| 2026-02-20 | 7.5 | 0 | CALL | 0 | 0 | 80.55 | TRUE | 0 | 0 |
| 2026-02-20 | 10 | 0.55 | CALL | 0 | 10 | 10.86 | FALSE | 0 | 0 |
| 2026-02-20 | 12.5 | 0 | CALL | 0 | 0 | 51.14 | FALSE | 0 | 0 |
| 2026-02-20 | 15 | 0 | CALL | 0 | 0 | 65.56 | FALSE | 0 | 0 |
| 2026-02-20 | 17.5 | 0 | CALL | 0 | 0 | 93.3 | FALSE | 0 | 0 |
| 2026-02-20 | 2.5 | 0 | PUT | 0 | 0 | 136.75 | FALSE | 0 | 0 |
| 2026-02-20 | 5 | 0 | PUT | 0 | 0 | 82.63 | FALSE | 0 | 0 |
| 2026-02-20 | 7.5 | 0.01 | PUT | 0 | 21 | 12.35 | FALSE | 0 | 0 |
| 2026-02-20 | 10 | 1.55 | PUT | 0 | 388 | 30.84 | TRUE | 0 | 0 |
| 2026-02-20 | 12.5 | 4.3 | PUT | 0 | 1 | 46.94 | TRUE | 0 | 0 |
| 2026-02-20 | 15 | 0 | PUT | 0 | 0 | 53.11 | TRUE | 0 | 0 |
| 2026-02-20 | 17.5 | 0 | PUT | 0 | 0 | 64.51 | TRUE | 0 | 0 |
| 2027-01-15 | 2.5 | 5 | CALL | 0 | 2 | 337.26 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 4.22 | CALL | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 7.5 | 1.15 | CALL | 0 | 43 | 118.93 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 0.05 | CALL | 0 | 517 | 6.3 | FALSE | 0 | 0 |
| 2027-01-15 | 12.5 | 0.05 | CALL | 0 | 65 | 14.07 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 3 | CALL | 0 | 33 | 20.44 | FALSE | 0 | 0 |
| 2027-01-15 | 17.5 | 0 | CALL | 0 | 0 | 100.36 | FALSE | 0 | 0 |
| 2027-01-15 | 2.5 | 0 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0 | PUT | 0 | 6 | 30.65 | FALSE | 0 | 0 |
| 2027-01-15 | 7.5 | 0.01 | PUT | 0 | 5095 | 8.84 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 1.55 | PUT | 0 | 1660 | 22.81 | TRUE | 0 | 0 |
| 2027-01-15 | 12.5 | 4.9 | PUT | 0 | 0 | 36.45 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 6.3 | PUT | 0 | 20 | 47.41 | TRUE | 0 | 0 |
| 2027-01-15 | 17.5 | 0 | PUT | 0 | 0 | 56.21 | TRUE | 0 | 0 |
Latest SAGE Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 10 | $32 |
| Jun 13, 2022 7:59 PM EST | 7 | $31.98 |
| Jun 13, 2022 7:59 PM EST | 37 | $31.98 |
| Jun 13, 2022 7:59 PM EST | 100 | $31.98 |
| Jun 13, 2022 7:59 PM EST | 1 | $31.99 |
Sage Therapeutics, Inc (SAGE) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm |
| 2020-07-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1597553/000000000020006722/0000000000-20-006722-index.htm |
| 2020-09-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1597553/000000000020008250/0000000000-20-008250-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000008025519002669/0000080255-19-002669-index.htm |
| 2020-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000008025520000011/0000080255-20-000011-index.htm |
| 2020-04-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000008025520001438/0000080255-20-001438-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000021545719005781/0000215457-19-005781-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000031506619001342/0000315066-19-001342-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000031506620001221/0000315066-20-001221-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000083423720006703/0000834237-20-006703-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000093247119006113/0000932471-19-006113-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000110465920017946/0001104659-20-017946-index.htm |
| 2018-12-18 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1597553/000119312518352130/0001193125-18-352130-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519003129/0001193125-19-003129-index.htm |
| 2019-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519014879/0001193125-19-014879-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519043460/0001193125-19-043460-index.htm |
| 2019-02-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1597553/000119312519043509/0001193125-19-043509-index.htm |
| 2019-02-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1597553/000119312519049853/0001193125-19-049853-index.htm |
| 2019-02-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1597553/000119312519052905/0001193125-19-052905-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519052913/0001193125-19-052913-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519053991/0001193125-19-053991-index.htm |
| 2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519079860/0001193125-19-079860-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1597553/000119312519119608/0001193125-19-119608-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1597553/000119312519119616/0001193125-19-119616-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519133822/0001193125-19-133822-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519167248/0001193125-19-167248-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519173095/0001193125-19-173095-index.htm |
| 2019-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519200528/0001193125-19-200528-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519213484/0001193125-19-213484-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519289188/0001193125-19-289188-index.htm |
| 2019-12-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312519306717/0001193125-19-306717-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520050968/0001193125-20-050968-index.htm |
| 2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1597553/000119312520051038/0001193125-20-051038-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520076535/0001193125-20-076535-index.htm |
| 2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520100489/0001193125-20-100489-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1597553/000119312520124472/0001193125-20-124472-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1597553/000119312520124474/0001193125-20-124474-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520136314/0001193125-20-136314-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520165675/0001193125-20-165675-index.htm |
| 2020-08-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1597553/000119312520208158/0001193125-20-208158-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520214068/0001193125-20-214068-index.htm |
| 2020-08-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1597553/000119312520225608/0001193125-20-225608-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520261295/0001193125-20-261295-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520269896/0001193125-20-269896-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1597553/000119312520286184/0001193125-20-286184-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218018004912/0001562180-18-004912-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218018004913/0001562180-18-004913-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000187/0001562180-19-000187-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm |
| 2019-01-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000487/0001562180-19-000487-index.htm |
| 2019-01-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000488/0001562180-19-000488-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000489/0001562180-19-000489-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000490/0001562180-19-000490-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000994/0001562180-19-000994-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001008/0001562180-19-001008-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001029/0001562180-19-001029-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001030/0001562180-19-001030-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001031/0001562180-19-001031-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001032/0001562180-19-001032-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001033/0001562180-19-001033-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001034/0001562180-19-001034-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm |
| 2019-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003388/0001562180-19-003388-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003389/0001562180-19-003389-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003390/0001562180-19-003390-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003391/0001562180-19-003391-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003392/0001562180-19-003392-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003393/0001562180-19-003393-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003394/0001562180-19-003394-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003395/0001562180-19-003395-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003636/0001562180-19-003636-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003637/0001562180-19-003637-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003638/0001562180-19-003638-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003639/0001562180-19-003639-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003640/0001562180-19-003640-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm |
| 2019-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020000275/0001562180-20-000275-index.htm |
| 2020-02-04 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020000855/0001562180-20-000855-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001240/0001562180-20-001240-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001242/0001562180-20-001242-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001243/0001562180-20-001243-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001244/0001562180-20-001244-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001245/0001562180-20-001245-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020001246/0001562180-20-001246-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003221/0001562180-20-003221-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003222/0001562180-20-003222-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003223/0001562180-20-003223-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003224/0001562180-20-003224-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003225/0001562180-20-003225-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003226/0001562180-20-003226-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003386/0001562180-20-003386-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004425/0001562180-20-004425-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004426/0001562180-20-004426-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004427/0001562180-20-004427-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004428/0001562180-20-004428-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004429/0001562180-20-004429-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004430/0001562180-20-004430-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm |
| 2020-10-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020006282/0001562180-20-006282-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1597553/000156218020006284/0001562180-20-006284-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1597553/000156223020000051/0001562230-20-000051-index.htm |
| 2019-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1597553/000156459019003191/0001564590-19-003191-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459019015034/0001564590-19-015034-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459019028984/0001564590-19-028984-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459019042533/0001564590-19-042533-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1597553/000156459020007021/0001564590-20-007021-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459020022891/0001564590-20-022891-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459020038597/0001564590-20-038597-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1597553/000156459020050861/0001564590-20-050861-index.htm |
| 2020-05-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1597553/999999999720003221/9999999997-20-003221-index.htm |
Sage Therapeutics, Inc (SAGE) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sage Therapeutics, Inc (SAGE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 161%Institutional Ownership: 9380%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-02-12 | KEVIN P STARR | Director | Sell | 0.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm | ||
| 2019-05-10 | Anne Marie Cook | SVP, GC & Secretary | Sell | 15,000.00 | 166.14 | 2,492,100.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Buy | 40,356.00 | 0.45 | 18,160.20 | 102,471.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-12-09 | Albert Robichaud | Chief Scientific Officer | Buy | 6,935.00 | 1.36 | 9,431.60 | 102,592.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm |
| 2019-07-17 | KIMI IGUCHI | CFO & Treasurer | Buy | 4,000.00 | 1.36 | 5,440.00 | 10,409.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm |
| 2019-08-15 | JAMES M FRATES | Director | Buy | 8,000.00 | 28.35 | 226,800.00 | 10,535.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm |
| 2019-12-09 | Albert Robichaud | Chief Scientific Officer | Buy | 5,732.00 | 38.25 | 219,249.00 | 108,324.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 4,200.00 | 173.41 | 728,322.00 | 109,704.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-02-15 | STEVEN M PAUL | Director | Sell | 12,519.00 | 161.02 | 2,015,809.38 | 111,385.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-12-09 | Albert Robichaud | Chief Scientific Officer | Buy | 3,076.00 | 28.63 | 88,065.88 | 111,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 1,619.00 | 172.20 | 278,791.80 | 113,904.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 500.00 | 171.01 | 85,505.00 | 115,523.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Buy | 53,908.00 | 0.45 | 24,258.60 | 116,023.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-01-23 | JAMES M FRATES | Director | Buy | 7,500.00 | 8.92 | 66,900.00 | 11,735.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm |
| 2019-05-29 | JEFFREY M JONAS | President & CEO | Sell | 475.00 | 171.39 | 81,410.54 | 12,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-05-06 | JAMES M FRATES | Director | Buy | 8,000.00 | 8.92 | 71,360.00 | 12,235.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm |
| 2019-03-21 | STEVEN M PAUL | Director | Sell | 1,967.00 | 161.02 | 316,726.34 | 122,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm |
| 2019-07-25 | KIMI IGUCHI | CFO & Treasurer | Buy | 2,000.00 | 1.36 | 2,720.00 | 12,409.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm |
| 2019-03-21 | STEVEN M PAUL | Director | Sell | 2,919.00 | 161.05 | 470,104.95 | 124,367.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm |
| 2019-05-29 | JEFFREY M JONAS | President & CEO | Sell | 400.00 | 170.40 | 68,158.00 | 12,590.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-03-21 | STEVEN M PAUL | Director | Sell | 2,993.00 | 161.04 | 481,992.72 | 127,286.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm |
| 2019-05-29 | JEFFREY M JONAS | President & CEO | Sell | 200.00 | 169.16 | 33,832.00 | 12,990.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-03-20 | STEVEN M PAUL | Director | Sell | 13,047.00 | 161.35 | 2,105,133.45 | 130,279.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Sell | 2,545.00 | 177.62 | 452,033.23 | 13,190.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-12-09 | Albert Robichaud | Chief Scientific Officer | Buy | 25,000.00 | 64.16 | 1,604,000.00 | 136,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm |
| 2019-03-01 | KIMI IGUCHI | CFO & Treasurer | Sell | 25,563.00 | 156.93 | 4,011,601.59 | 1,413.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm |
| 2019-07-25 | KIMI IGUCHI | CFO & Treasurer | Buy | 1,900.00 | 14,309.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm | ||
| 2019-03-20 | STEVEN M PAUL | Director | Sell | 13,096.00 | 161.32 | 2,112,646.72 | 143,326.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-05-10 | Anne Marie Cook | SVP, GC & Secretary | Buy | 15,000.00 | 28.63 | 429,450.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm |
| 2019-03-20 | STEVEN M PAUL | Director | Sell | 16,182.00 | 161.20 | 2,608,538.40 | 156,422.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Sell | 11,662.00 | 176.44 | 2,057,673.60 | 15,735.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-03-20 | STEVEN M PAUL | Director | Sell | 14,321.00 | 161.32 | 2,310,263.72 | 172,604.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-18 | STEVEN M PAUL | Director | Sell | 875.00 | 161.01 | 140,883.75 | 186,925.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-18 | STEVEN M PAUL | Director | Sell | 800.00 | 161.02 | 128,816.00 | 187,800.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-18 | STEVEN M PAUL | Director | Sell | 1,200.00 | 161.14 | 193,368.00 | 188,600.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-18 | STEVEN M PAUL | Director | Sell | 900.00 | 161.01 | 144,909.00 | 189,800.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm |
| 2019-03-01 | STEVEN M PAUL | Director | Sell | 700.00 | 161.00 | 112,700.00 | 190,700.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm |
| 2019-03-01 | STEVEN M PAUL | Director | Sell | 700.00 | 161.00 | 112,700.00 | 191,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm |
| 2019-03-01 | STEVEN M PAUL | Director | Sell | 500.00 | 161.00 | 80,500.00 | 192,100.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm |
| 2019-03-01 | STEVEN M PAUL | Director | Sell | 700.00 | 161.00 | 112,700.00 | 192,600.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm |
| 2019-08-15 | JAMES M FRATES | Director | Sell | 8,000.00 | 160.58 | 1,284,640.00 | 2,535.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm |
| 2019-05-22 | Michael Cloonan | Chief Business Officer | Buy | 25,000.00 | 73.43 | 1,835,750.00 | 25,461.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm |
| 2019-07-25 | Anne Marie Cook | SVP, GC & Secretary | Buy | 1,900.00 | 2,600.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm | ||
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Sell | 16,651.00 | 175.72 | 2,925,880.42 | 27,397.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-07-25 | Stephen Kanes | Chief Medical Officer | Buy | 1,900.00 | 2,841.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm | ||
| 2019-12-09 | KIMI IGUCHI | CFO & Treasurer | Buy | 15,000.00 | 1.36 | 20,400.00 | 28,761.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm |
| 2019-12-10 | KIMI IGUCHI | CFO & Treasurer | Buy | 500.00 | 1.36 | 680.00 | 29,261.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm |
| 2019-07-25 | Michael Cloonan | Chief Business Officer | Buy | 2,450.00 | 3,190.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm | ||
| 2020-04-30 | KIMI IGUCHI | CFO & Treasurer | Buy | 4,000.00 | 1.36 | 5,440.00 | 33,261.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm |
| 2019-07-16 | JEFFREY M JONAS | President & CEO | Buy | 27,000.00 | 0.45 | 12,150.00 | 39,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm |
| 2019-01-23 | JAMES M FRATES | Director | Sell | 7,500.00 | 134.81 | 1,011,075.00 | 4,235.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm |
| 2019-05-06 | JAMES M FRATES | Director | Sell | 8,000.00 | 162.22 | 1,297,760.00 | 4,235.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm |
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Sell | 28,293.00 | 174.48 | 4,936,667.32 | 44,048.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-07-25 | JEFFREY M JONAS | President & CEO | Buy | 5,000.00 | 44,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm | ||
| 2019-05-22 | Michael Cloonan | Chief Business Officer | Sell | 25,000.00 | 175.00 | 4,375,000.00 | 461.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm |
| 2019-09-11 | JEFFREY M JONAS | President & CEO | Buy | 4,600.00 | 0.45 | 2,070.00 | 47,030.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm |
| 2019-12-09 | JEFFREY M JONAS | President & CEO | Buy | 7,500.00 | 64.20 | 481,500.00 | 54,530.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm |
| 2019-03-08 | KIMI IGUCHI | CFO & Treasurer | Buy | 4,723.00 | 0.45 | 2,125.35 | 6,136.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm |
| 2019-01-09 | JEFFREY M JONAS | President & CEO | Buy | 10,000.00 | 0.45 | 4,500.00 | 62,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 1,763.00 | 176.15 | 310,552.45 | 62,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Sell | 950.00 | 177.76 | 168,872.00 | 62,115.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Sell | 2,518.00 | 176.80 | 445,182.40 | 63,065.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 14,727.00 | 175.09 | 2,578,550.43 | 63,878.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Sell | 3,974.00 | 175.79 | 698,589.46 | 65,583.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Sell | 24,966.00 | 175.02 | 4,369,549.32 | 69,557.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-05-10 | Anne Marie Cook | SVP, GC & Secretary | Buy | 700.00 | 56.27 | 39,389.00 | 700.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm |
| 2019-02-25 | STEVEN M PAUL | Director | Sell | 500.00 | 161.00 | 80,500.00 | 70,900.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm |
| 2019-02-25 | STEVEN M PAUL | Director | Sell | 500.00 | 161.00 | 80,500.00 | 71,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm |
| 2019-02-25 | STEVEN M PAUL | Director | Sell | 500.00 | 161.00 | 80,500.00 | 71,900.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm |
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Sell | 25,510.00 | 173.62 | 4,428,933.96 | 72,341.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-02-25 | STEVEN M PAUL | Director | Sell | 500.00 | 161.00 | 80,500.00 | 72,400.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm |
| 2019-02-19 | STEVEN M PAUL | Director | Sell | 200.00 | 162.00 | 32,400.00 | 72,900.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-19 | STEVEN M PAUL | Director | Sell | 643.00 | 161.37 | 103,760.91 | 73,100.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-19 | STEVEN M PAUL | Director | Sell | 500.00 | 161.62 | 80,812.00 | 73,743.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-19 | STEVEN M PAUL | Director | Sell | 200.00 | 162.00 | 32,400.00 | 74,243.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-15 | STEVEN M PAUL | Director | Sell | 12,388.00 | 161.02 | 1,994,715.76 | 74,443.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-05-23 | JEFFREY M JONAS | President & CEO | Sell | 31,099.00 | 174.46 | 5,425,531.54 | 78,605.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-09-04 | Stephen Kanes | Chief Medical Officer | Buy | 6,000.00 | 0.45 | 2,700.00 | 8,292.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm |
| 2019-02-15 | STEVEN M PAUL | Director | Sell | 12,044.00 | 161.02 | 1,939,324.88 | 86,831.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |
| 2019-02-08 | Stephen Kanes | Chief Medical Officer | Sell | 22,948.00 | 150.00 | 3,442,200.00 | 941.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm |
| 2019-05-24 | JEFFREY M JONAS | President & CEO | Sell | 7,948.00 | 174.05 | 1,383,349.40 | 94,523.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm |
| 2019-07-25 | Albert Robichaud | Chief Scientific Officer | Buy | 1,900.00 | 96,205.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm | ||
| 2019-05-28 | JEFFREY M JONAS | President & CEO | Buy | 35,736.00 | 0.45 | 16,081.20 | 97,851.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm |
| 2019-02-15 | STEVEN M PAUL | Director | Sell | 12,510.00 | 161.02 | 2,014,360.20 | 98,875.00 | https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm |